Transcode Therapeutics, Inc. · NASDAQ:RNAZ
CK Life Sciences Intl (Holdings) Inc converted 13,834,441 Transcode Therapeutics, Inc. shares (Form 4)
Traded Aug 3, 2026 · Filed Aug 5, 2026
On Aug 3, 2026, CK Life Sciences Intl (Holdings) Inc (10% owner) converted 13,834,441 Transcode Therapeutics, Inc. shares, leaving 14,134,481 shares. Filed Aug 5, 2026 (Form 4).
- Converted
- 13,834,441 shares
- Holding after
- 14,134,481 shares
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Common Stock | Conversion | 11,813,859 | 12,113,899 | Direct | |
| Aug 3, 2026 | Common Stock | Conversion | 2,020,582 | 14,134,481 | Direct |
Source
Related
- Transcode Therapeutics, Inc.
- CK Life Sciences Intl (Holdings) Inc
- Transcode Therapeutics, Inc. shareholders
- Schedule 13D/A · CK Life Sciences Intl (Holdings) Inc · Aug 3, 2026
- Schedule 13G · Daniel Eduardo Katzman · Jul 28, 2026
- Schedule 13G · Elena Rosa Braci · Jul 28, 2026
- Schedule 13G · Unleash Immuno Oncolytics, Inc. · Jul 28, 2026
- Schedule 13D/A · CK Life Sciences Intl (Holdings) Inc · Jul 27, 2026